تفاعل #2446111
ord-ae1e1b1119c54cfaa846259f4c90670c
معادلة التفاعل
المتفاعلات
الكواشف
ظروف التفاعل
المعالجة
- 1أخرىin dry
- 2أخرىdegassed tetrahydrofuran (120 mL)
- 3workup.STIRRINGThe mixture was stirred at −5° C. for 30 min
- 4workup.STIRRINGThe reaction was stirred at room temperature for 2 h
- 5تركيزThe mixture was concentrated under vacuum to half of its initial volume
- 6workup.ADDITIONEtOAc (50 mL) was added
- 7أخرىlayers were separated
- 8غسيلThe organic phase was further washed with water (3×20 mL) and brine (40 mL)
- 9تركيزwas concentrated
- 10أخرىThe residue was purified by silica gel chromatography
- 11أخرىto afford a white foam in 55% yield (7.0 g, 13.4 mmol)
- 12workup.STIRRINGstirred for 1 h
- 13تركيزThe solution was then concentrated under vacuum
الإجراء التجريبي
Oxycodone free base (6.5 g, 20.6 mmol) was dissolved in dry, degassed tetrahydrofuran (120 mL), and the mixture was cooled to −10° C. using a dry ice/acetone bath. Potassium bis(trimethylsilyl)amide (KHMDS) (103.0 mL, 51.6 mmol, 0.5 M in toluene) was added via cannula. The mixture was stirred under N2 at below −5° C. for 30 min. N,N-Bis(tert-butyl) N′-2-(chlorocarbonyl(methyl)amino)ethylcarbamate (8.0 g, 23.7 mmol), (Compound C) in THF (30 mL) was then added via cannula over 15 min. The mixture was stirred at −5° C. for 30 min. Another portion of carbamoyl chloride (4.0 g, 11.9 mmol) in THF (10 mL) was added. The reaction was stirred at room temperature for 2 h. Sodium bicarbonate (10 mL, sat. aq.) was added. The mixture was concentrated under vacuum to half of its initial volume. EtOAc (50 mL) was added, and layers were separated. The organic phase was further washed with water (3×20 mL) and brine (40 mL), and then was concentrated. The residue was purified by silica gel chromatography, using DCM/MeOH (gradient 100/1 to 100/15) to afford a white foam in 55% yield (7.0 g, 13.4 mmol). This material was dissolved in a 1:1 mixture of DCM/trifluoroacetic acid (TFA) (20 mL/20 mL) at room temperature and stirred for 1 h. The solution was then concentrated under vacuum to afford a TFA salt of oxycodone 6-(N-methyl-N-(2-amino)ethylcarbamate (Compound KC-19) as a thick oil (7.3 g, 11.4 mmol, 99% purity). MS: (m/z) calc: 415.2, observed (M+H+) 416.5.